Nucleic acids and methods for the detection of coagulase-negative staphylococcus
CA 2811455 C · Owner: Geneohm Sciences Canada Inc. · Inventors: Huletsky, Ann; Bergeron, Michel G.; Boissinot, Maurice
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Nucleic acids, methods and diagnostic kits derived therefrom for detecting in a , sample at least one microorganism belonging to the coagulase-negative Staphylococcus group are provided. The method comprises i) contacting the sample , with at least one group-specific oligonucleotide selected to be sufficiently complementary to hybridize to at least one tuf nucleic acid specific to the group; ii) , Allowing the oligonucleotide and the tuf nucleic acid to hybridize under conditions , such that the oligonucleotide hybridizes to the tuf nucleic acid wherein the , oligonucleotide hybridizes only to microorganisms belonging to the coagulasenegative , Staphylococcus group and does not …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 28, 2000 and granted December 8, 2015. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 28, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 28, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.